sNDA Accepted for Relistor for Opioid Induced Constipation - MPR
Links shared publicly online about this topic.
- 34total visits
sNDA Accepted for Relistor for Opioid Induced Constipation - MPR
empr.com —
Progenics Pharmaceuticals and Salix Pharmaceuticals announced that the FDA has accepted for filing a supplemental New Drug Application (sNDA) for Relistor (methylnaltrexone bromide) Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.
View full resource at empr.com
Tags: Constipation, Pain, Drug, Pharma, FDA, Opiate
Most Recently Shared on August 30, 2011 at 3:40 pm By:
sNDA Accepted for Relistor for Opioid Induced Constipation http://ow.ly/6gE3t #relistor
FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation
news-medical.net — “Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Ltd. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for RELISTOR Subcutaneous Injection to treat opioid-induced constipation (OIC) in patients with non-cancer pain.” View full resource at news-medical.net
Most Recently Shared on August 30, 2011 at 12:21 pm By:
FDA accepts Salix and Progenics' sNDA filing for RELISTOR to treat opioid-induced constipation: Progenics Pharma... http://t.co/EODNrFc
Advertisement
